MedTrace Logo

Memory Deterioration in Alzheimer Disease

NCT07118137 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2025-08-12

No results posted yet for this study

Summary

Semantic AD

Conditions

Interventions

DEVICE

7T MRI

Resting and activity-based MRI. Dring activity based MRI, the participant will complete tasks testing semantic memory.

DEVICE

EEG

Resting-state EEG

BIOLOGICAL

Blood samples

Blood samples taken for analysis of central blood biomarkers.

BIOLOGICAL

Stool samples

Stool samples collected to identify distinct gut-microbiota compositions between the groups.

DIAGNOSTIC_TEST

Neuropsychologic test (MoCA)

Map cognition with clinically well-established neuropsychology test

Sponsors & Collaborators

  • Norwegian University of Science and Technology

    lead OTHER

Principal Investigators

  • Axel Sandvig Professor, MD PhD · Norwegian University of Science and Technology (NTNU)

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-15
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07118137 on ClinicalTrials.gov